Cost of Cystic Fibrosis Therapy Orkambi too High for Low Benefit, Say U.K.’s NICE
Cystic Fibrosis, News
The U.K.’s National Institute for Health and Care Excellence (NICE) announced that is does not recommend funding a cystic fibrosis (CF) treatment Orkambi through Vertex Pharmaceuticals at this time. In March, ... Read more